List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 25 February 2026 - 13:23
List of medicinal products under additional monitoring
Cancer Medicines Forum: December 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 2 December 2025, 16:00 (CET) to 2 December 2025, 17:00 (CET)
Submitted by Anonymous (not verified) on 25 February 2026 - 9:44
Cancer Medicines Forum: December 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 2 December 2025, 16:00 (CET) to 2 December 2025, 17:00 (CET)
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 January 2026, 13:30 (CET) to 30 January 2026, 15:30 (CET)
Submitted by Anonymous (not verified) on 25 February 2026 - 8:09
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 January 2026, 13:30 (CET) to 30 January 2026, 15:30 (CET)
EMEA-003618-PIP01-24
Submitted by Anonymous (not verified) on 25 February 2026 - 7:33
EMEA-003618-PIP01-24
Electronic reporting to EudraVigilance - List of reference documents
Submitted by Anonymous (not verified) on 24 February 2026 - 16:22
Electronic reporting to EudraVigilance - List of reference documents
Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised
Submitted by Anonymous (not verified) on 24 February 2026 - 16:12
Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised
EudraVigilance training and support
Submitted by Anonymous (not verified) on 24 February 2026 - 15:57
EudraVigilance training and support
EudraVigilance support guide
Submitted by Anonymous (not verified) on 24 February 2026 - 15:49
EudraVigilance support guide
EudraVigilance - EVWEB user manual
Submitted by Anonymous (not verified) on 24 February 2026 - 15:41
EudraVigilance - EVWEB user manual
Human medicines European public assessment report (EPAR): Exelon, rivastigmine, Date of authorisation: 11/05/1998, Revision: 51, Status: Authorised
Submitted by Anonymous (not verified) on 24 February 2026 - 15:38
Human medicines European public assessment report (EPAR): Exelon, rivastigmine, Date of authorisation: 11/05/1998, Revision: 51, Status: Authorised